达安基因 (002030)
Daan Gene Co., Ltd.
K-Line Chart
No K-line data available
Company NameGuangzhou Da'an Gene Co., Ltd.
Listing Date2004-08-09
Issue Price7.3RMB
Registered Capital140344.603210k RMB
Legal RepresentativeWei Dianhan
Registered AddressNo. 19 Xiangshan Road, Science City, High-tech Industrial Development Zone, Guangzhou City, Guangdong Province
IndustryMedical Devices
Main BusinessResearch, development, and application of fluorescent PCR detection technology.
Company ProfileGuangzhou Da'an Gene Co., Ltd. is a high-tech biomedical enterprise focused on molecular diagnostic technology, integrating the R&D, production, and sales of clinical testing reagents and instruments, as well as nationwide chain independent medical laboratory clinical testing services. The company has maintained a leading position in molecular biology technology, especially in the research, development, and application of gene diagnostic technology and its reagent products.
Stock Details
1. Key Indicators
- Total Shares(W): 140344.60
- Circulating A-Shares(W): 140344.60
- Earnings Per Share(RMB): -0.1000
- Net Assets Per Share(RMB): 5.5155
- Operating Revenue(W RMB): 50350.69
- Total Profit(W RMB): -16957.33
- Net Profit Attributable to Parent(W RMB): -14150.46
- Net Profit Growth Rate(%): 71.85
- Weighted Return on Equity(%): -1.8100
- Operating Cash Flow Per Share(RMB): 0.0580
- Undistributed Profit Per Share(RMB): 3.1849
- Capital Reserve Per Share(RMB): 0.4301
2. Main Business
The main business covers:
- Research, production, and sales of clinical testing reagents, instruments, and supporting consumables.
3. Company Basic Information
- Company Name: Daan Gene Co., Ltd.
- Listing Date: 2004-08-09
- Industry: Pharmaceutical Manufacturing
- Address: No. 19 Xiangshan Road, Science City, High-tech Industrial Development Zone, Guangzhou, Guangdong Province, China
- Website: www.daangene.com
- Company Profile：The company was established by the overall change and initiation of Sun Yat-sen Medical University Daan Gene Co., Ltd. The initiators included Sun Yat-sen Medical University (later merged with the original Sun Yat-sen University and collectively referred to as Sun Yat-sen University), Guangzhou Bioengineering Center, Wang Youming, Hongta Investment, Dongsheng Investment, Liu Qiang, Guosen Securities, Tongchuang Weiye, He Yunshao, Cheng Gang, Zhou Xinyu, and Wu Junsheng. The registered capital at the time of establishment was 34.70 million yuan. After two distributions of bonus shares from distributable profits to shareholders in 2001 and 2002, the current registered capital is 61.60 million yuan.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Guangzhou Guangyong Technology Development Co., Ltd. | General Legal Person | 23339.20 | 16.63 |
| 2 | Guangzhou Biomedical and Health Industry Investment Co., Ltd. | General Legal Person | 14034.46 | 10.00 |
| 3 | Guangzhou Financial Holding Group Co., Ltd. | General Legal Person | 7017.23 | 5.00 |
| 4 | Central Huijin Asset Management Co., Ltd. | Special Legal Person | 1281.79 | 0.91 |
| 5 | Hong Kong Securities Clearing Company Ltd. | Northbound Funds | 1112.01 | 0.79 |
| 6 | Yongwin CSI All Share Medical Devices ETF | Fund | 605.85 | 0.43 |
5. Concept Sectors
- Venture Capital Concept
- Biological Vaccine
- Food Safety
- Internet Finance
- Gene Concept
- Artificial Intelligence
- Helicobacter Pylori
- Assisted Reproduction
- Hepatitis Concept
- Margin Trading & Securities Lending
- University Background
- Participation in New Share Issuance
- Consecutive Losses
- National Team (Central Huijin & China Securities Finance)
- Equity Transfer
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information